Adverse events during radical prostatectomy and their association with recurrence and death - Top-Institutions - MDSpire

Adverse events during radical prostatectomy and their association with recurrence and death

  • By

  • Sofia Erestam

  • Ying Li

  • Eva Angenete

  • Anders Bjartell

  • Carolina Ehrencrona

  • Jonas Hugosson

  • Anna Lantz

  • Peter Wiklund

  • Eva Haglind

  • September 23, 2025

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Surgical Oncology
    • Robotic Surgery

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Oncology
    • Robotic Surgery

  • #3

    Karolinska Institutet and Karolinska University Hospital
    Karolinska Institutet and Karolinska University Hospital

    Stockholm, Stockholm County

    Key Differentiators

    • Urology
    • Oncology
    • Robotic Surgery

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urology
    • Surgical Oncology
    • Robotic Surgery

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Oncology
    • Robotic Surgery

Original Source(s)

Adverse events during radical prostatectomy and their association with recurrence and death

  • by Sofia Erestam, Ying Li, Eva Angenete, Anders Bjartell, Carolina Ehrencrona, Jonas Hugosson, Anna Lantz, Peter Wiklund, Eva Haglind

  • September 23, 2025

Related Content

Posterior urethroplasty for pelvic fracture urethral injuries: risk factors for recurrence and complications

Flexible ureteroscopy in renal anomalies: an explainable AI model for surgical outcome prediction from EAU endourology

Post-surgical outcomes in transgender women: a prospective analysis of sexual function and health-related quality of life